How big is the finasteride market?
According to 6Wresearch internal database and industry insights,
Global finasteride market was valued at
USD 0.9 Billion in 2024 and is expected to reach
USD 1.3 Billion by 2031, growing at a
compound annual growth rate of 6.63% during the forecast period (2025-2031).
Growth is driven by the increasing prevalence of androgenetic alopecia, expanding male grooming trends, and rising awareness of treatment options for benign prostatic hyperplasia (BPH). It is further supported by advancements in drug formulations, increasing healthcare expenditure, and growing acceptance of preventive and aesthetic healthcare solutions.
Key Growth Factors of the Finasteride Market
- Rising incidence of male pattern baldness Worldwide
- Increasing awareness and diagnosis of benign prostatic hyperplasia (BPH)
- Expanding use of prescription and OTC finasteride products
- Growth of online direct-to-consumer telehealth platforms
- Favorable reimbursement for BPH medications in developed markets
- Availability of generic alternatives enhancing affordability
Finasteride Market Trends
The finasteride market is witnessing a surge in online sales of hair loss treatments, subscription-based delivery models, and telemedicine consultations. There is also a trend toward lower-dose formulations and combination therapies. Consumer preferences are shifting toward discreet and convenient channels for purchasing treatment.
Emerging Developments in the Finasteride Market
Emerging developments in the finasteride market include topical finasteride formulations, micro-dosing strategies to reduce side effects, and clinical trials for new indications. Market players are also investing in DTC branding, personalized regimens, and improved delivery systems for better efficacy and compliance.
Leading Companies in the Finasteride Market
- Merck & Co., Inc.
- Teva Pharmaceutical Industries Ltd.
- Dr. Reddy Laboratories Ltd.
- Cipla Inc.
- Sun Pharmaceutical Industries Ltd.
- Lupin Limited
How big is the finasteride market : FAQs
The finasteride market is projected to reach USD 1.3 billion by 2031.
The finasteride market is expected to grow at a CAGR of 6.3% during the forecast period.
Finasteride is mainly used for androgenetic alopecia (hair loss) and benign prostatic hyperplasia (BPH).
North America and Europe lead in prescription volume, while Asia-Pacific is growing due to increasing awareness and affordability.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on
sales@6wresearch.com